Milford, MA 12/11/08—Waters has lowered its revenue and non-GAAP EPS forecast for the fourth quarter as a result of weaker than expected instrument orders and deteriorating economic conditions. The company now expects fourth-quarter sales to decline 4%–6% to $410–$420 million, including negative currency effects of approximately 4%. Previous guidance was approximately $454 million in sales, […]
The latest figures from IMS Health show that worldwide sales for generic drugs increased just 3.6% to $78 billion for the twelve months ending in September, compared to 11.4% growth for the same period last year. The decline is attributed to price competition. In the US, the world’s largest generics market, where generics make up […]
One of the more exciting developments in technology for life science research has been the adoption of medical imaging technologies for use with research animals. The ability to image animals in vivo not only reduces the need to sacrifice animals, but also enhances the information obtained from animal studies by allowing a researcher to follow […]
Milford, MA 12/5/08—Waters has purchased the net assets of Analytical Products Group (APG), a proficiency testing and quality-assurance services company, for an undisclosed amount. Waters will merge APG with its Environmental Resource Associates operations. APG has annual revenues of approximately $4 million. The acquisition is expected to be neutral to Waters’s 2009 earnings.
Cambridge, MA 12/2/08; Washington, DC 12/2/08; Washington, DC 12/3/08—Helicos BioSciences, which this year commercialized the HeliScope DNA sequencer, has announced the appointment of Ronald Lowy as part-time CEO. He replaces Steve Lombardi, who will continue as president and as a Board member. Mr. Lowy was president and CEO of Fisher Scientific from November 2004 to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
